LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said that a late stage trial of its MAGE-A3 cancer immunotherapeutic for patients with non-small-cell lung cancer did not meet two of its co-primary endpoints, as it failed to extend disease-free survival compared to a placebo. It did no Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br /><strong>----------</strong><br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE CUTS HSBC TO 'UNDERPERFORM' ('OUTPERFORM,') - PRICE TARGET 580 (780) PENCE <br />----------<br Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said Moncef Slaoui, chairman of research and development, acquired American Depositary Shares at USD54.23 each Friday.<br /><br />Details are as follows. <table class="ak" style="width: 419px; height: 130px;" cellspacing="0" cellpadding="0 Read More
LONDON (Alliance News) - It's all about retailers Thursday, with the listed supermarkets all down sharply due to even weaker-than-expected results and a warning about this year from <strong>Wm Morrison Supermarkets</strong>, while Argos and Homebase parent <strong>Home Retail</strong> rose sha Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a pivotal phase III study of mepolizumab, an investigational IL-5 antagonist monoclonal antibody, has met its primary endpoint of reduction in the frequency of exacerbations, in patients with severe eosinophilic asthma. The study e Read More
LONDON (Alliance News) - The FTSE 100 overturned early strength to close lower Monday, as investors digested some weaker-than-expected Chinese trade data released over the weekend, amid a lack of fresh major macro-economic data releases. A report from the Chinese General Administration of C Read More
LONDON (Alliance News) - London's capital markets continued a resurgence Monday as two more companies announced that they intend to list, another started trading, and AIM-listed <strong>Fyffes PLC</strong> said it would be acquired by Chiquita Brands International Inc of the US in a deal that Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />Chiquita Brands International Inc and <strong>Fyffes</strong> PLC said they have reached a deal whereby Chiquita will acquire Fyffes to create th Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />DEUTSCHE BANK CUTS ROLLS-ROYCE PRICE TARGET TO 860 (1090) PENCE - 'SELL'<br />----------<br />MERRILL LYNCH Read More
LONDON (Alliance News) - Shares have opened higher Monday despite a weak lead from Asia.<br /><br />M&A and share placings have grabbed attention at the open. <br /><br />Chiquita Brands International Inc and <strong>Fyffes</strong> PLC said they will merge to create the world's largest ba Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Monday launched the GBP629 million open offer to increase its stake in its Indian unit to 75%, from 50.7%, a deal it had announced back in September. In a statement, the company said it will offer INR3,100 a share for up to 20.6 milli Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said Moncef Slaoui, a divisional chairman was allocated 15 American Depositary shares under the company share plan at a price of USD55.94 per ADS Friday. Shares in the global healthcare company closed at 1,662.50 pence down 0.5% Monday.</p Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Chief Executive Andrew Witty took a hit to his annual bonus for 2013 as a result of ongoing investigations in China, although his total pay for the year still rose 63% as the company got six products approved and five additional regulatory filings comp Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Chief Executive Andrew Witty took a hit to his annual bonus for 2013 as a result of ongoing investigations in China, although Witty's total pay for the year still rose 63% as the company saw six products approved and five additional regulatory filings Read More
LONDON (Alliance News) - GlaxoSmithKline said Friday that it had submitted a new drug application to the US Food and Drug Administration for its severe aplastic anaemia treatment Promacta. The treatment is used for patients with the condition who have had an insufficient response to immunos Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a group of executives sold shares for tax purposes in the health company at a price of GBP16.73 per share Monday.<br /><br />Details are as follows.<br /><br /> <table class="af" cellspacing="0" cellpadding="0"><tbody><tr><td class Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said Executive Director Moncef Slaoui, General Counsel Dan Troy and Diedre Connelly, a divisional president, had American Depositary Shares withheld for tax purposes at a price of USD55.69 per ADS as part of the company share plan Monday.< Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives including Roger Connor a divisional president and Philip Thomson, a divisional senior vice president acquired shares while General Counsel James Ford and Executive Director Moncef Slaoui acquired American Depositar Read More
LONDON (Alliance News) - The FTSE 100 closed higher for the sixth consecutive day Friday, closing less than 100 points short of its 2014 opening level as investors shrugged off a host of weaker-than-expected UK and US data releases to ensure the global equity rally continues. The FTSE 100 c Read More
LONDON (Alliance News) - The FTSE 100 closed higher for the sixth consecutive day Friday, closing less than 100 points short of its 2014 opening level as investors shrugged off a host of weaker-than-expected UK and US data releases to ensure the global equity rally continues. The FTSE 100 c Read More